Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma Article

Industry Collaboration International Collaboration

cited authors

  • O'Malley, David M.; Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne, I; Clamp, Andrew R.; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W.; Gancedo, Margarita Amenedo; Fong, Peter C.; Goh, Jeffrey C.; Swisher, Elizabeth M.; Maloney, Lara; Goble, Sandra; Lin, Kevin K.; Kwan, Tanya; Ledermann, Jonathan A.; Coleman, Robert L.

authors

Publication Date

  • December 1, 2022

webpage

published in

category

keywords

  • Genomics
  • Ovarian carcinoma
  • Rucaparib
  • Safety

start page

  • 404

end page

  • 413

volume

  • 167

issue

  • 3